Authors
Latest:
Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty PharmacyThe National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.
Latest:
Long Acting Reversible Contraceptives and Chlamydia: No Increased RiskA team of researchers from Columbia University, New York City compared the incidence of chlamydia infection in adolescent LARC users to non-LARC users.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Reimagining Specialty Pharmacy: Market Variability Drives New StrategiesA common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.
Latest:
Effect of Dispensing Supply on Pravastatin Refill AdherenceIn uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.
Latest:
The Value Potential of Biosimilars in the United StatesPharmacists must understand the potential value of biosimilars as a competitive generation of more cost efficient drugs hit the market.
Latest:
Leukemia: Causes, Symptoms, and TreatmentsLeukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.
Latest:
Making Sense of Allergic Rhinitis: A Pharmacist's Primer on General Overview and Treatment of Allergic RhinitisPharmacists can learn about current management of allergic rhinitis, including allergen avoidance, immunotherapy, and pharmacotherapy.
Latest:
Point-of-Care Testing Offers New OpportunitiesConsider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Latest:
Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.
Latest:
The Addiction Crisis in America’s Hospitals: Clinical Drug DiversionHealth care compliance analytics can be used to roll out institution-wide training and education programs to deter sloppy or nefarious behavior related to controlled substances.
Latest:
Making Sense of Motivational Interviewing, Part 2: Clinical, Economic, and Other EvidenceNumerous studies have supported the use of motivational interviewing in health care to reduce cholesterol level, blood pressure, blood alcohol level, and weight.
Latest:
Emerphed: The Role of Pre-Filled Ephedrine for Emergencies in the Operating RoomThe pharmacy department is generally responsible for making prepared syringes to be distributed prior to procedures.
Latest:
Protein S DeficiencyProtein S deficiency is a type of inherited thrombophilia associated with increased risk of venous thromboembolism.
Latest:
FDA Approves Nasal Spray Treatment for MigraineThe FDA has approved sumatriptan nasal spray (Tosymra, Promius Pharma) for the acute treatment of migraine with or without aura in adults.
Latest:
Real-World Dosing and Utilization of Ustekinumab Among Patients With PsoriasisThis study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
PLEI Perspectives: Will the Real Leaders Please Stand and Be Recognized?Those who think that leadership is only about a title held by a select few are sadly mistaken.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
What You Need to Know About Probiotics in Your DietHaving a healthy gut with the right balance of good bacteria may change the entire health of our bodies.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
